SCHEMBL2918906

SCHEMBL2918906

O=C(Nc1ccc2nc(CN3CCCCC3)ccc2c1)c1ccc(-c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 10/20 0.69
HTR2C P28335 7/20 0.69
MLLT1 Q03111 2/20 0.54
POLB P06746 1/20 0.51
CYP3A4 P08684 1/20 0.51
GAA P10253 1/20 0.51
CYP2D6 P10635 1/20 0.51
THRB P10828 1/20 0.51
CYP2C19 P33261 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 2/20 0.50
FAAH O00519 1/20 0.50
TRPV1 Q8NER1 3/20 0.48
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
PIR O00625 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2925096 0.91 MCHR1 (0.80) MCHR1HTR2CMLLT1POLBCYP3A4
SCHEMBL2925651 0.90 MCHR1 (0.81) MCHR1HTR2CMLLT1POLBCYP3A4
SCHEMBL13177227 0.84 MCHR1 (0.51) MCHR1HTR2CMLLT1POLBCYP3A4
SCHEMBL13177221 0.84 MCHR1 (0.51) MCHR1HTR2CMLLT1POLBCYP3A4
SCHEMBL2917966 0.84 MCHR1 (0.81) MCHR1HTR2CTRPV1
SCHEMBL2926586 0.84 MCHR1 (0.81) MCHR1HTR2CMLLT1SMN1; SMN2TRPV1
SCHEMBL2926866 0.83 MCHR1 (0.74) MCHR1HTR2CMLLT1POLBCYP3A4
SCHEMBL2925591 0.83 MCHR1 (0.80) MCHR1HTR2CMLLT1POLBCYP3A4
SCHEMBL2926869 0.83 MCHR1 (0.98) MCHR1HTR2CMLLT1SMN1; SMN2FAAH
SCHEMBL2921144 0.83 MCHR1 (0.83) MCHR1HTR2CFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1285651-B1 MELANIN CONCENTRATING HORMONE ANTAGONISTS TAKEDA PHARMACEUTICAL (JP) 2010-09-01 EP disclosed
US-6930185-B2 Melanin-concentrating hormone antagonist TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-16 US disclosed
US-20040077628-A1 Melanin-concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-22 US disclosed
EP-1285651-A1 MELANIN CONCENTRATING HORMONE ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077628-A1 Melanin-concentrating hormone antagonist MCHR1, MC1R, MCHR2 MCHR1 1/4885HTR2C 107/4885MLLT1 3428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.